1. Qing, Ying, Dong, Lei, Gao, Lei, Su, Rui, Chen, Jianjun. . R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis. In Molecular cell, 81, 922-939.e9. doi:10.1016/j.molcel.2020.12.026. https://pubmed.ncbi.nlm.nih.gov/33434505/
2. Liu, Weiwei, Ding, Zhao, Tao, Ye, Zha, Xiaojun, Liu, Yehai. 2024. A positive feedback loop between PFKP and c-Myc drives head and neck squamous cell carcinoma progression. In Molecular cancer, 23, 141. doi:10.1186/s12943-024-02051-6. https://pubmed.ncbi.nlm.nih.gov/38982480/
3. Ling, Xiaodong, Zhang, Luquan, Fang, Chengyuan, Liang, Hao, Ma, Jianqun. 2024. A comprehensive prognostic and immunological implications of PFKP in pan-cancer. In Cancer cell international, 24, 310. doi:10.1186/s12935-024-03497-w. https://pubmed.ncbi.nlm.nih.gov/39252014/
4. Zhang, Zongwei, Liang, Wei, Luo, Qiang, Chi, Qingjia, Ding, Guohua. 2022. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease. In Frontiers in endocrinology, 12, 797025. doi:10.3389/fendo.2021.797025. https://pubmed.ncbi.nlm.nih.gov/35095764/
5. Peng, Jian, Li, Pingping, Li, Yuan, Yuan, Dajiang, Wang, Xiaoru. 2023. PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer. In Scientific reports, 13, 17399. doi:10.1038/s41598-023-43982-2. https://pubmed.ncbi.nlm.nih.gov/37833332/
6. de Wet, Larischa, Williams, Anthony, Gillard, Marc, Szmulewitz, Russell Z, Vander Griend, Donald J. 2022. SOX2 mediates metabolic reprogramming of prostate cancer cells. In Oncogene, 41, 1190-1202. doi:10.1038/s41388-021-02157-x. https://pubmed.ncbi.nlm.nih.gov/35067686/
7. Lang, Liwei, Chemmalakuzhy, Ron, Shay, Chloe, Teng, Yong. . PFKP Signaling at a Glance: An Emerging Mediator of Cancer Cell Metabolism. In Advances in experimental medicine and biology, 1134, 243-258. doi:10.1007/978-3-030-12668-1_13. https://pubmed.ncbi.nlm.nih.gov/30919341/
智鼠故事 
